|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/12/20 Biosynergy Inc 10-Q 1/31/20 41:1.1M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 124K
2: EX-31.1 Certification of Chief Executive Officer HTML 18K
3: EX-31.2 Certification of Chief Accounting Officer HTML 18K
5: EX-32 Certification -- §906 - SOA'02 HTML 13K
4: EX-32.1 Certification Pursuant to 18 U.S.C. Section 1350 HTML 13K
as Adopted
27: R1 Document and Entity Information HTML 45K
38: R2 Balance Sheets (Unaudited) HTML 101K
34: R3 Balance Sheets (Parenthetical) HTML 21K
16: R4 Statements of Operations (Unaudited) HTML 57K
26: R5 Statements of Cash Flows (Unaudited) HTML 66K
37: R6 Shareholders Equity (Unaudited) HTML 24K
33: R7 Company Organization and Description HTML 19K
15: R8 Summary of Significant Accounting Policies HTML 40K
28: R9 Inventories HTML 19K
14: R10 Common Stock HTML 16K
24: R11 Related Party Transactions HTML 24K
36: R12 Lease Commitments HTML 18K
32: R13 Customer Concentration HTML 19K
13: R14 Depreciation HTML 16K
23: R15 Research and Development and Patents HTML 17K
35: R16 Summary of Significant Accounting Policies HTML 88K
(Policies)
31: R17 Summary of Significant Accounting Policies HTML 23K
(Tables)
12: R18 Inventories (Tables) HTML 20K
25: R19 Related Party Transactions (Tables) HTML 22K
40: R20 Summary of Significant Accounting Policies - HTML 27K
Income Tax Rate (Details)
30: R21 Summary of Significant Accounting Policies - HTML 23K
Provision for Income Taxes (Details)
18: R22 Depreciation (Details Narrative) HTML 16K
22: R23 Research and Development and Patents (Details HTML 17K
Narrative)
39: R24 Inventories - Inventories (Details) HTML 22K
29: R25 Related Party Transactions (Details Narrative) HTML 22K
17: R26 Lease Commitments - Future Minimum Lease Expense HTML 20K
(Details)
21: R27 Customer Concentrations (Details) HTML 21K
41: XML IDEA XML File -- Filing Summary XML 64K
20: EXCEL IDEA Workbook of Financial Reports XLSX 31K
11: EX-101.INS XBRL Instance -- bsyn-20200131 XML 236K
7: EX-101.CAL XBRL Calculations -- bsyn-20200131_cal XML 98K
8: EX-101.DEF XBRL Definitions -- bsyn-20200131_def XML 56K
9: EX-101.LAB XBRL Labels -- bsyn-20200131_lab XML 304K
10: EX-101.PRE XBRL Presentations -- bsyn-20200131_pre XML 223K
6: EX-101.SCH XBRL Schema -- bsyn-20200131 XSD 55K
19: ZIP XBRL Zipped Folder -- 0000715812-20-000002-xbrl Zip 41K
EXHIBIT 31.2
CERTIFICATION OF CHIEF ACCOUNTING OFFICER
I, Laurence C. Mead, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Biosynergy, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: March 12, 2020
| /s/ Laurence C. Mead |
|
Laurence C. Mead Vice President/Manufacturing and Development, Chief Financial Officer, and Chief Accounting Officer
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/12/20 | None on these Dates | ||
| For Period end: | 1/31/20 | |||
| List all Filings | ||||